Focus Antitrust - 3 March 2021
In The News
Competition Appeal Tribunal dismisses Lexon’s appeal against the CMA’s nortriptyline decision
The Competition Appeal Tribunal has upheld the CMA’s decision fining Lexon £1.2 million for exchanging commercially sensitive information with other suppliers of nortriptyline. Click here.
- The CMA has announced that it is to consider undertakings in lieu of a reference offered by Adevinta ASA and eBay Inc. in relation to the anticipated acquisition by Adevinta ASA of eBay Classifieds Group. Click here.